Adam S. Komorowski

825 total citations · 1 hit paper
27 papers, 494 citations indexed

About

Adam S. Komorowski is a scholar working on Infectious Diseases, Statistics and Probability and Economics and Econometrics. According to data from OpenAlex, Adam S. Komorowski has authored 27 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 7 papers in Statistics and Probability and 6 papers in Economics and Econometrics. Recurrent topics in Adam S. Komorowski's work include Statistical Methods in Clinical Trials (7 papers), Meta-analysis and systematic reviews (6 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Adam S. Komorowski is often cited by papers focused on Statistical Methods in Clinical Trials (7 papers), Meta-analysis and systematic reviews (6 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Adam S. Komorowski collaborates with scholars based in Canada, South Africa and Saudi Arabia. Adam S. Komorowski's co-authors include Rossanna C. Pezo, Katarzyna J. Jerzak, Arjun Sahgal, Anthony D. Bai, Carson K. L. Lo, Mark Loeb, Pranav Tandon, Alex Kiss, Yizhuo Gao and Markus Kuksis and has published in prestigious journals such as JAMA, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Adam S. Komorowski

22 papers receiving 490 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis

2022 150 citations Anthony D. Bai, Carson K. L. Lo et al. Clinical Microbiology and Infection profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adam S. Komorowski Canada	10	161	158	152	97	85	27	494
Jessica Lewis United States	11	169 1.0×	36 0.2×	137 0.9×	56 0.6×	87 1.0×	22	602
Frans H. Krouwels Netherlands	15	123 0.8×	454 2.9×	39 0.3×	100 1.0×	31 0.4×	24	945
F Mohammadi Iran	14	72 0.4×	117 0.7×	271 1.8×	99 1.0×	17 0.2×	72	602
Irfan Vaziri United States	7	89 0.6×	45 0.3×	100 0.7×	41 0.4×	10 0.1×	11	296
Clara Minotti Italy	13	160 1.0×	15 0.1×	104 0.7×	100 1.0×	43 0.5×	35	490
Goh Ohji Japan	13	39 0.2×	82 0.5×	153 1.0×	82 0.8×	38 0.4×	47	510
Dimple Chudasama United Kingdom	13	146 0.9×	98 0.6×	136 0.9×	93 1.0×	9 0.1×	40	475
S. Thongprasert United States	4	365 2.3×	345 2.2×	178 1.2×	111 1.1×	25 0.3×	5	599
Spartaco Sani Italy	7	461 2.9×	337 2.1×	61 0.4×	104 1.1×	44 0.5×	12	875
Thomas M. Elliott Australia	14	134 0.8×	60 0.4×	30 0.2×	53 0.5×	50 0.6×	28	432

Countries citing papers authored by Adam S. Komorowski

Since Specialization

Citations

This map shows the geographic impact of Adam S. Komorowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam S. Komorowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam S. Komorowski more than expected).

Fields of papers citing papers by Adam S. Komorowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam S. Komorowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam S. Komorowski. The network helps show where Adam S. Komorowski may publish in the future.

Co-authorship network of co-authors of Adam S. Komorowski

This figure shows the co-authorship network connecting the top 25 collaborators of Adam S. Komorowski. A scholar is included among the top collaborators of Adam S. Komorowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam S. Komorowski. Adam S. Komorowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Komorowski, Adam S., Michael G. Surette, Laura Rossi, et al.. (2025). Molecular Epidemiology of Clinical Infections Caused by Serratia marcescens Complex in a Tertiary Care Hospital System: Insights From Whole-Genome Sequencing. The Journal of Infectious Diseases. 232(4). e589–e600.

Komorowski, Adam S., Alireza Eshaghi, Austin Zygmunt, et al.. (2025). Detection of non-travel-associated, ceftriaxone non-susceptible Neisseria gonorrhoeae FC428-like harbouring the mosaic penA60 allele in Ontario, Canada. Canada Communicable Disease Report. 51(10/11/12). 420–426.

Komorowski, Adam S., Lawrence Mbuagbaw, Mangalakumari Jeyanathan, et al.. (2025). AeroVax: study protocol for a randomised, double-blind, placebo-controlled phase 2 trial to evaluate safety and immunogenicity of a next-generation COVID-19 vaccine delivered by inhaled aerosol to humans. ERJ Open Research. 11(3). 758–2024.

Komorowski, Adam S., Clayton W. Hall, Robert Walker, et al.. (2024). Cerebrospinal fluid galactomannan detection for the diagnosis of central nervous system aspergillosis: a diagnostic test accuracy systematic review and meta-analysis. Clinical Microbiology and Infection. 30(10). 1244–1253. 6 indexed citations

Komorowski, Adam S.. (2023). mutterseelenallein. JAMA. 330(8). 773–773.

Lo, Carson K. L., Adam S. Komorowski, Clayton W. Hall, et al.. (2023). Methodological and Reporting Quality of Noninferiority Randomized Controlled Trials Comparing Antiretroviral Therapies: A Systematic Review. Clinical Infectious Diseases. 77(7). 1023–1031. 4 indexed citations

Komorowski, Adam S., Carson K. L. Lo, Marek Smieja, et al.. (2023). More Than a Decade Since the Latest CONSORT Non-inferiority Trials Extension: Do Infectious Diseases Trials Do Enough?. Clinical Infectious Diseases. 78(2). 324–329. 1 indexed citations

Wang, Michael, Stefan D. Jevtic, Ryan Rebello, & Adam S. Komorowski. (2023). Lenalidomide-Associated Progressive Multifocal Leukoencephalopathy. 18(2). 12–17. 1 indexed citations

Bai, Anthony D., Carson K. L. Lo, Adam S. Komorowski, et al.. (2022). How Generalizable Are Randomized Controlled Trials (RCTs) in Staphylococcus aureus Bacteremia? A Description of the Mortality Gap Between RCTs and Observational Studies. Clinical Infectious Diseases. 75(8). 1449–1452. 10 indexed citations

10.

Bai, Anthony D., Carson K. L. Lo, Adam S. Komorowski, et al.. (2022). Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis. Clinical Microbiology and Infection. 28(8). 1076–1084. 150 indexed citations breakdown →

11.

Komorowski, Adam S., et al.. (2021). Meningitis caused by Mycobacterium tuberculosis in a recent immigrant to Canada. Canadian Medical Association Journal. 193(47). E1807–E1810. 2 indexed citations

12.

Bai, Anthony D., Adam S. Komorowski, Carson K. L. Lo, et al.. (2021). Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review. BMC Medical Research Methodology. 21(1). 75–75. 21 indexed citations

13.

Komorowski, Adam S., Anthony D. Bai, Carson K. L. Lo, et al.. (2021). Secondary Analysis of a Systematic Review: Are Antifungal Noninferiority Trials at Risk of Eroding Effectiveness Because of Biocreep?. Antimicrobial Agents and Chemotherapy. 66(1). 4 indexed citations

14.

Bai, Anthony D., Adam S. Komorowski, Carson K. L. Lo, et al.. (2021). Confidence interval of risk difference by different statistical methods and its impact on the study conclusion in antibiotic non-inferiority trials. Trials. 22(1). 708–708. 2 indexed citations

15.

Komorowski, Adam S., Helen Mackay, & Rossanna C. Pezo. (2020). Quality of adverse event reporting in phase III randomized controlled trials of breast and colorectal cancer: A systematic review. Cancer Medicine. 9(14). 5035–5050. 9 indexed citations

16.

Kuksis, Markus, Yizhuo Gao, William T. Tran, et al.. (2020). The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis. Neuro-Oncology. 23(6). 894–904. 142 indexed citations

17.

Bai, Anthony D., Adam S. Komorowski, Carson K. L. Lo, et al.. (2020). Methodological and Reporting Quality of Noninferiority Randomized Controlled Trials Comparing Antibiotic Therapies: A Systematic Review. Clinical Infectious Diseases. 73(7). e1696–e1705. 11 indexed citations

18.

Komorowski, Adam S., Ellen Warner, Helen Mackay, et al.. (2019). Incidence of Brain Metastases in Nonmetastatic and Metastatic Breast Cancer: Is There a Role for Screening?. Clinical Breast Cancer. 20(1). e54–e64. 40 indexed citations

19.

Komorowski, Adam S. & Rossanna C. Pezo. (2019). Untapped “-omics”: the microbial metagenome, estrobolome, and their influence on the development of breast cancer and response to treatment. Breast Cancer Research and Treatment. 179(2). 287–300. 38 indexed citations

20.

Komorowski, Adam S. & Sang Ik Song. (2018). A politics of the senses: the political role of theKing’s-Evil in Richard Wiseman’sSeverall Chirurgicall Treatises. Medical Humanities. 45(3). 288–294.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact